Stock 858 EXTRAWELL PHARMACEUTICAL HOLDINGS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Extrawell Pharmaceutical Holdings Limited

Equities

858

BMG3285Q1134

Pharmaceuticals

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:28 2024-05-24 EDT 		5-day change 1st Jan Change
0.038 HKD -2.56% Intraday chart for Extrawell Pharmaceutical Holdings Limited -5.00% +11.76%
2023 Extrawell Pharmaceutical Swings to Fiscal H1 Loss on Fair Value Losses MT
2023 Extrawell Pharmaceutical Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2023 CI

Business Summary

Extrawell Pharmaceutical Holdings Ltd is an investment holding company principally engaged in the development, manufacture and sale of pharmaceuticals. The Company operates its business through three segments. The Manufacturing segment is engaged in the development, manufacture and sales of pharmaceutical products. Its self-produced products include Transfer Factor Oral Solution, Wisk, ZhouBang and others. The Trading segment is engaged in the promotion and distribution of imported pharmaceuticals. Its imported products include Millibar and Skin Cap. The Gene Development segment is engaged in the commercial development and research, development of gene-related technologies.

Number of employees: 169

Sales per Business

HKD in Million2022Weight2023Weight Delta
Manufacturing
100.0 %
74 100.0 % 73 100.0 % -1.83%
Trading
0.0 %
0 0.0 % 0 0.0 % -

Sales per region

HKD in Million2022Weight2023Weight Delta
China
100.0 %
74 100.0 % 73 100.0 % -1.83%
Hong Kong
0.0 %
0 0.0 % 0 0.0 % -

Managers

Managers TitleAgeSince
Yi Xie CEO
 Chief Executive Officer 61 -
Hong Wu DFI
 Director of Finance/CFO 52 -
Yong Cheng BRD
 Director/Board Member 61 13-12-04
Sau Kuen Wong BRD
 Director/Board Member 61 08-04-30

Members of the board

Members of the board TitleAgeSince
Yi Lou BRD
 Director/Board Member 66 08-10-05
Sau Kuen Wong BRD
 Director/Board Member 61 08-04-30
Yi Xie CEO
 Chief Executive Officer 61 -
Lin Hu Fang BRD
 Director/Board Member 86 00-12-31
Song Jin BRD
 Director/Board Member 53 03-12-31
Yi Guo BRD
 Director/Board Member 43 23-04-13
Yong Cheng BRD
 Director/Board Member 61 13-12-04

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 2,390,000,000 1,908,490,000 ( 79.85 %) 0 79.85 %

Company contact information

Extrawell Pharmaceutical Holdings Ltd.

Suites 2206-08, 22nd floor Devon House, Taikoo Place

, Hong Kong

+

http://www.extrawell.com.hk
address Extrawell Pharmaceutical Holdings Limited(858)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
EXTRAWELL PHARMACEUTICAL HOLDINGS LIMITED Stock Extrawell Pharmaceutical Holdings Limited
+11.76% 11.62M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+38.51% 727B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+33.05% 599B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.23% 354B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.78% 328B
ABBVIE INC. Stock AbbVie Inc.
+1.35% 277B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.00% 243B
NOVARTIS AG Stock Novartis AG
+8.09% 205B
ROCHE HOLDING AG Stock Roche Holding AG
-5.77% 203B
AMGEN INC. Stock Amgen Inc.
+6.19% 164B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 858 Stock
  4. Company Extrawell Pharmaceutical Holdings Limited